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The chromosomal instability of polyploid cells, which leads to the formation of aneuploid
cells, is causally related to carcinogenesis in human tissues. However, the precise link
between the chromosomal instability of polyploid cells and oncogenic transformation of
them remains elusive. This is partly because we lack an experimental model in which
non-transformed polyploid human cells can propagate in vitro. In a previous report, we
demonstrated that proliferative tetraploid cells can be established fromTIG-1 human fibrob-
lasts by treatment with the spindle poison demecolcine (DC, colcemid) for 4 days. However,
this procedure could not be applied to other human fibroblast strains because the result-
ing cells proliferated as a mixture of diploid and tetraploid populations. Here, we report
a modified procedure to establish proliferative tetraploid cells from human fibroblasts of
the BJ strain with minimum contamination by diploid cells. In the modified procedure,
DC-arrested mitotic cells were collected by mitotic shake-off and treated with DC for an
additional 3 days. DC-treated cells restarted proliferation as tetraploid cells after several
days of growth arrest and showed similar growth to that of untreated diploid cells. The
MDM2 antagonist Nutlin-3a activated p53 in established tetraploid cells and suppressed
their growth, indicating that these cells have functional p53.These results contradicted the
hypothesis that p53 functions as the tetraploidy checkpoint and prevents proliferation of
tetraploid cells. Tetraploid cells established by our method could be a valuable model for
the study of chromosomal instability and the oncogenic potential of polyploid cells.
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INTRODUCTION
In the early stages of human carcinogenesis, polyploid (mostly
tetraploid) cells often arise and form preneoplastic lesions that
give rise to malignant aneuploid cells. Although near-diploid ane-
uploidy is also prevalent in tumors and polyploidy is not the
only route to generate aneuploid cells (1), recent research sug-
gests that the formation of polyploid cells and their chromosomal
instability appear to be causally related to human carcinogen-
esis. For example, increased tetraploid populations in Barrett’s
esophagus predict progression to aneuploidy and esophageal car-
cinoma (2, 3). Tetraploidy and chromosomal instability are early
events during cervical carcinogenesis and predispose cervical cells
to aneuploidy (4, 5). However, the precise relationship between the
chromosomal instability of polyploid cells and oncogenic trans-
formation remains elusive. This is partly because we lack a suitable
experimental model in which non-transformed polyploid human
cells can propagate in vitro.
In a previous study, we demonstrated that proliferative
tetraploid cells can be established from non-transformed human
fibroblasts (TIG-1) by treatment with the spindle poison demecol-
cine (DC) (6). TIG-1 cells treated with DC for 4 days resumed
proliferation at approximately 1 week after DC treatment and
became almost completely tetraploid at 2 weeks after treatment.
Established tetraploid cells grew at the same rate as untreated
diploid cells and showed a similar life span as the original cells.
However, we were unable to apply this procedure to other human
fibroblast cell strains (TIG-3, IMR-90, BJ), which were somewhat
resistant to polyploidy and maintained a significant diploid sub-
population after DC treatment. In the present study, we developed
a modified procedure for the induction and isolation of polyploid
cells and showed that the method is effective for the establishment
of proliferative tetraploid cells from BJ human fibroblasts with
minimum contamination by diploid cells.
MATERIALS AND METHODS
CELL CULTURE
BJ normal human fibroblasts, which were originally established
from normal human foreskin, at 21 population doubling levels
(PDLs) were obtained from American Type Culture Collection
(VA, USA). Cells were grown in minimum essential medium with
α modification (MEM-α; Sigma-Aldrich Co., St. Louis, MO, USA)
supplemented with heat-inactivated 10% (v/v) fetal bovine serum.
Cells were incubated in a 5% (v/v) CO2 atmosphere at 37°C and
passaged every 3 or 4 days, ensuring that cells never exceeded sub-
confluent density. These cells grew up to 60 PDLs or more before
they reach a state of senescence. For immunofluorescent studies,
cells were seeded onto sterile glass slides, placed into culture dishes,
and incubated for 2 days before staining.
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INDUCTION AND ESTABLISHMENT OF POLYPLOID CELLS FROM BJ
CELLS
Cells under eight passages (equivalent to PDL ≤40) were used
for induction of polyploidy. The method described in a previous
report (6), which was based on the method reported by Fujikawa-
Yamamoto et al. (7), was modified to induce the formation of
polyploid cells from BJ fibroblasts. Exponentially growing BJ cells
in T75 flasks were treated with medium containing 0.1µg/ml DC.
After 16–18 h of DC treatment, DC-arrested mitotic cells were
collected by gentle shaking of the flask and washing with medium
followed by centrifugation. The time point for collection of mitotic
cells was determined by preliminary observation using time-lapse
recording to obtain as many mitotic cells as possible. In additional
preliminary experiments, collection of mitotic cells at different
time points between 0 and 24 h of DC treatment yielded the highest
number of cells at 16–18 h. Therefore, this time point was used for
recovery of mitotic cells in subsequent experiments. Mitotic cells
collected by the shake-off method were reseeded into 60 mm cul-
ture dishes and treated with DC for an additional 3 days. Usually,
cells collected from six T75 flasks were seeded into one or two
60 mm culture dishes, subjected to additional DC treatment, and
then incubated in drug-free medium. Cells were harvested at the
indicated time points, and DNA content was analyzed with a BD
CycleTEST™ Plus DNA Reagent Kit (BD Biosciences, USA) and a
BD FACSCanto II flow cytometer (Becton Dickinson, USA).
CHROMOSOME ANALYSIS AND FLUORESCENCE IN SITU
HYBRIDIZATION
Chromosome slides were prepared by standard procedures after
cells were treated with DC for 6 h. At least 100 metaphase cells
per time point were digitally photographed, and the chromosome
number per cell was scored using image analysis software (ImageJ
1.44p) after manual separation of touching and overlapping chro-
mosomes using the photo editing software Photoshop Elements.
For fluorescence in situ hybridization (FISH) analysis, cells were
processed and fixed as for chromosome analysis. Fixed cells were
heat-denatured and hybridized with a SpectrumOrange-labeled
centromere probe for chromosome 11 and a SpectrumGreen-
labeled centromere probe for chromosome X (Abbott Molecular
Inc. Des Plaines, IL, USA) according to the manufacturer’s instruc-
tions. Signals for chromosome 11 and X in at least 1000 interphase
cells per experiment were scored using a fluorescence microscope
equipped with appropriate filters.
ANALYSIS OF CENTROSOMES
We examined the number and localization of centrosomes
in mitotic tetraploid cells by immunofluorescence to confirm
whether bipolar divisions contribute to propagation of tetraploid
BJ cells. Cells cultured on a glass slide were fixed with 2%
(v/v) formaldehyde, permeabilized with 0.25% (v/v) Triton X-100,
and incubated for 1 h at room temperature with mouse mon-
oclonal antibodies against α-tubulin (Sigma T9025, 1:800 dilu-
tion) and centrin-2 (Santa Cruz SC-27793-R, 1:800 dilution), fol-
lowed by Alexa Fluor 488-conjugated goat anti-mouse IgG (Mol-
ecular Probes, 1:500 dilution) and Alexa Fluor 555-conjugated
goat anti-rabbit IgG (Molecular Probes, 1:500 dilution). Cells
were then treated with RNase (0.5 mg/ml) containing 5µg/ml
4′,6-diamidino-2-phenylindole (DAPI). DNA content was mea-
sured by DAPI fluorescence using a laser scanning cytometer
(LSC-2, Olympus, Japan) equipped with a violet (405 nm) laser
and a blue channel filter (460–485 nm). Chromosomes, mitotic
spindle, and centrosomes in mitotic cells were inspected using
appropriate filter sets, and localization of chromosomes and num-
ber of centrosomes were scored in at least 50 mitotic cells per time
point after DC treatment.
ANALYSIS OF p53 FUNCTION
To examine the p53 status of untreated BJ cells and established
tetraploid cells, the effect of Nutlin-3a (NT) on gene expression
and cell growth was analyzed. NT stabilizes p53 by blocking its
interaction with the E3 ubiquitin ligase MDM2, which promotes
its proteasomal degradation. Therefore, NT treatment should acti-
vate p53 downstream proteins such as p21 and suppresses the
growth of cells in which p53 is functional. To examine the effect of
NT on p53 and p21 expression, cells seeded on glass slides in a pre-
vious day were treated with 10µM NT for 24 h. Cells were then
fixed with 2% formaldehyde solution for 30 min, permeabilized
with 0.25% (v/v) Triton X-100, and incubated with mouse mon-
oclonal antibody against p53 (clone DO-1, 1:100 dilution, Santa
Cruz Biotechnology) or p21 (clone F-5, 1:200 dilution, Santa Cruz
Biotechnology), followed by Alexa Fluor 488-conjugated goat anti-
mouse IgG (Molecular Probes, 1:500 dilution). Cells were then
treated with RNase (0.5 mg/ml) containing 5µg/ml propidium
iodide (PI) and analyzed with a LSC-2 laser scanning cytometer
(Olympus, Japan). The frequency of p53 positive cells was esti-
mated by comparing the fluorescence intensity with that of cells
incubated with isotype control antibody. The effect of NT on cell
growth was examined by treating cells with 10µM NT contin-
uously for 3 days, and cell growth was analyzed by counting cell
numbers every day during the treatment.
RESULTS
ESTABLISHMENT OF POLYPLOID CELLS FROM BJ CELLS
Treatment of BJ cells with 0.1µg/ml DC continually for 4 days fol-
lowing the procedure described previously to establish tetraploid
cells from TIG-1 cells resulted in a mixture of diploid and
tetraploid populations (Figure 1A). On the other hand, DC-
arrested mitotic BJ cells collected by the shake-off method after
16–18 h of DC treatment consisted of cells with a 4C DNA content
and presumably apoptotic cells with a DNA content<2C, whereas
adherent cells had 2C and 4C DNA contents as determined by DNA
histograms (Figure 1B). The collected cells with 4C DNA were
then treated with DC for an additional 3 days to establish polyploid
cells. Additional DC treatment of less than 3 days was not suffi-
cient to establish polyploid cells, and cells reverted to diploid status
after DC treatment (data not shown). DC treatment resulted in a
significant number of floating cells, and approximately 10% of the
cells collected by shake-off had adhered to the culture dishes at the
end of treatment. Analysis of the DNA content by flow cytometry
at this time point showed 4C DNA and apoptotic cells (Figure 1C,
leftmost panels). After DC treatment, cells showed growth arrest
and large, flattened morphology for several days. After 5–7 days of
DC treatment, small proliferating cells appeared among the large
flattened cells (Figure 1C, middle panels), and cells became almost
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FIGURE 1 | Establishment of tetraploid cells from human fibroblasts by
treatment with demecolcine. (A) Changes in the DNA histograms of BJ
cells treated with demecolcine (DC) continually for 4 days. Numerals in the
histograms represent the time (days) after drug removal. The abscissa shows
DNA content (C, complement). (B) Phase-contrast micrograph of BJ cells
treated with DC for 16 h (left panel), and DNA histograms of mitotic cells
isolated by the shake-off method (right upper panel) and adherent cells (right
lower panel). (C) Changes in DNA histograms and morphology of cells
isolated by the shake-off method. Upper panels show DNA histograms and
lower panels show phase-contrast micrographs. The abscissa represents DNA
content (C, complement). (D) Growth profiles of untreated BJ cells (open
markers) and DC-treated cells (closed markers). The growth curve of
DC-treated cells was made based on the observation that 10% of mitotic cells
collected by shake-off had adhered to the dish at the end of DC treatment.
completely tetraploid at 2 weeks after DC treatment (Figure 1C,
rightmost panels). Less than 5% of contaminating diploid cells
was observed at this point, and these cells showed a tendency to
diminish with serial passaging. The mean frequency of diploid
cells at 4 weeks after DC treatment was 1.1% in three experiments.
Established tetraploid cells grew at almost the same rate as diploid
cells and showed an approximately equal replicative lifespan as
the original diploid cells (Figure 1D). The average doubling time
at 2–6 weeks after DC treatment was 44.5± 3.4 h in three exper-
iments, while the doubling time of untreated diploid cells in the
same period was 46.5± 2.6 h.
NUMBER OF CHROMOSOMES AND FISH SIGNALS AFTER
ESTABLISHMENT OF TETRAPLOID CELLS
The mode of chromosome counts in established tetraploid cells
was always 92 throughout the experimental period, and more
than 80% of the cells had tetraploid chromosome counts (91–
93 chromosomes) after 4 weeks of DC treatment (Figures 2A,B).
However, the frequency of cells with tetraploid chromosome
counts decreased to 51.0% and cells with reduced chromosome
counts (<91 chromosomes) increased to 45.0% at 6 weeks after
DC treatment. FISH analysis showed that approximately 95%
of cells had four signals for chromosome 11, and approximately
98% of cells had two signals for chromosome X at 2 and 4 weeks
after DC treatment, whereas the frequency of these cells decreased
slightly at 6 weeks after DC treatment (Figures 2C,D). At 6 weeks
after DC treatment, cells with <4 and >4 signals for chromo-
some 11 slightly increased, whereas for chromosome X, cells with
>2 signals slightly increased but cells with <2 signals did not
increase.
CENTROSOME NUMBER AND LOCALIZATION IN TETRAPLOID BJ CELLS
More than 80% of mitotic cells had 2 centrosomes, while 10–17%
of mitotic cells had excess centrosomes in established tetraploid
cells at analyzed time point after DC treatment (Figures 3A,B).
This frequency of mitotic cells with excess centrosomes in
tetraploid BJ cells was almost the same as the diploid BJ cells.
Centrosomes in tetraploid BJ cells were usually recognized by anti-
centrin-2 antibody as pairs of two dots presumably representing
centrioles, although some centrosomes had more than two
centrioles. While most metaphase cells with 2 centrosomes had
a bipolar spindle and aligned chromosomes, metaphase cells with
excess centrosomes were often accompanied by an irregular spin-
dle and misaligned chromosomes (Figure 3A). Presence of mis-
aligned chromosomes in metaphase cells was strongly correlated
with the presence of excess centrosomes (Figure 3C).
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FIGURE 2 | Chromosome and fluorescence in situ hybridization (FISH)
analysis of tetraploid BJ cells. (A) Photomicrograph of chromosomes from
an established tetraploid cell prepared after 16 days of DC treatment. (B)
Histograms of chromosome number in established tetraploid cells scored at
2, 4, and 6 weeks after DC treatment. Chromosomes were scored for at least
100 mitotic cells from two experiments per time point. The numbers on the
histogram bars represent frequencies of cells with <91, 91-93, >93
chromosomes respectively. (C) Photomicrograph of FISH in established
tetraploid cells prepared at 16 days after DC treatment. Orange signals
represent chromosome 11, and green signals represent chromosome X. Two
interphase cells and one mitotic cell show tetrasomy for chromosome 11 and
disomy for chromosome X, indicating that they are male tetraploid cells. (D)
Frequencies of FISH signals for chromosome 11 and X scored at 2, 4, and
6 weeks after DC treatment. Signals were scored for at least 1000 interphase
cells per experiment. Numbers in the accumulated bar graphs represent
frequencies of cells with the given number of signals.
ACTIVATION OF p53 AND GROWTH SUPPRESSION BY NT TREATMENT
Treatment of diploid BJ cells and established tetraploid cells with
10µM NT for 24 h resulted in the accumulation of the p53 and
p21 proteins in both cell types (Figure 4A). Continuous treat-
ment with the same concentration of NT suppressed cell growth
(Figure 4B), suggesting that p53 was functional in both cell
types.
DISCUSSION
In the present study, we showed that proliferative tetraploid cells
can be established from BJ human fibroblasts by a combination
of mitotic shake-off and DC treatment. The mitotic shake-off
method, which is used to synchronize the cell cycle of adherent
cells, is based on the fact that cells round up during mitosis and
can be dislodged from plastic culture dishes by agitation (8). The
collection of mitotic cells by the shake-off method enabled the
effective induction of tetraploid cells in BJ cells, because most
of adherent diploid cells can be eliminated by this method. The
difference in the response to DC treatment between BJ cells, in
which tetraploidy was not completely induced by the original
method, and TIG-1 cells, which became completely tetraploid
under similar conditions (6), is unknown at present. One possible
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FIGURE 3 | Centrosome analysis in tetraploid BJ cells. (A)
A representative dot plot showing DNA content vs. DNA condensation
obtained by laser scanning cytometry (leftmost panel), photomicrographs
of immunohistochemically stained mitotic cells in a 8C DNA subpopulation
(second to rightmost panels). Chromosomes are labeled with DAPI (blue),
mitotic spindles are labeled with anti-α-tubulin antibody (green),
centrosomes are labeled with anti-centrin-2 antibody (red ). Upper panels
show a metaphase cell with normal morphology, and lower panels show a
metaphase cell with misaligned chromosomes (arrows), an irregular-shaped
spindle and excess centrosomes. (B) Frequencies of mitotic cells with 2
centrosomes and excess centrosomes in established tetraploid cells.
Number of centrosomes was scored in at least 50 mitotic cells per time
point after DC treatment. Numbers in the accumulated bar graphs
represent frequencies of cells with the given number of centrosomes. (C)
The correlation between centrosome number and chromosome
misalignment in tetraploid metaphase cells. The frequency of metaphase
cells with aligned and misaligned chromosomes in pooled data from all
time points shown in (B) was calculated according to the centrosome
number. Numbers in the accumulated bar graphs represent frequencies of
metaphase cells with aligned and misaligned chromosomes.
explanation is that a significant population of BJ cells arrest at
G1 phase by DC treatment and resume proliferation after treat-
ment, whereas TIG-1 cells do not show G1 arrest in response to
the same treatment. Further investigation is necessary to verify this
hypothesis.
Several studies have shown that mammalian cells with func-
tional p53 arrest with a 4C DNA content in response to spindle
inhibitors, whereas cells lacking p53 re-replicate and become poly-
ploid (9–11). Andreassen et al. hypothesized that the tetraploid
state induces a p53-dependent arrest of non-transformed mam-
malian cells in G1 phase termed“tetraploidy checkpoint”(12), and
this hypothesis has been supported by other investigators (13, 14).
However, our results contradict this hypothesis because induced
tetraploid cells showed similar growth to that of untreated diploid
cells, despite the fact that they had functional p53. Induction of
proliferative tetraploid cells from non-transformed human cells
with functional p53 was also observed in TIG-1 human fibrob-
lasts (6). Therefore, the cell cycle arrest with 4C DNA content
in response to spindle inhibitors was probably not caused by
tetraploidy itself but may have been triggered by other factor(s).
The basis for this assumption is our observation that cell cycle
arrest with 4C DNA content after DC treatment was transient
but not permanent. In our experiment, treatment of BJ cells with
DC for 4 days coupled with isolation of 4C mitotic cells by the
shake-off method resulted in growth arrest for approximately 5–
7 days, followed by the resumption of proliferation as tetraploid
cells thereafter. Studies supporting the existence of a “tetraploidy
checkpoint” observed cell cycle arrest only during drug treatment
but failed to analyze growth recovery after drug treatment (9–11).
In fact, several studies have shown results supporting the lack of
checkpoints for tetraploidy in mammalian cells (15–19). These
studies suggest that drug treatments used to synchronize cells or
induce tetraploidy cause cellular damage that is likely to be DNA
damage, which results in G1 arrest with a 4C DNA content. Other
studies have indicated that prolonged mitotic arrest induced by
various mechanisms results in DNA damage (20, 21). If the growth
www.frontiersin.org August 2013 | Volume 3 | Article 198 | 5
Ohshima and Seyama Establishment of tetraploid cells
FIGURE 4 | Effect of Nutlin-3a (NT) on gene expression and cell growth
of diploid and tetraploid BJ cells. (A) p53 and p21 expression in
untreated and NT-treated cells. Cells on glass slides were treated with
10µM NT for 24 h and immunohistochemically stained with anti-p53 or
anti-p21 monoclonal antibody, then analyzed by a laser scanning cytometer
as described in the Section “Materials and Methods.”The regions indicating
positive expression were drawn above the fluorescence intensity of cells
incubated with isotype control antibody. Percentages in the figures indicate
frequencies of cells with positive expression of each gene. 2C and 4C
indicate the positions of cells with 2C and 4C DNA content. (B) Cell growth
of control and NT-treated diploid BJ cells (upper panel) and tetraploid BJ
cells (lower panel). Cells were treated with 10µM NT continuously.
arrest observed after DC treatment in our study was caused by
DNA damage, the resumption of cell growth after a recovery period
is reasonable. We are currently performing experiments to verify
this mechanism.
Although the chromosome number in established tetraploid
cells was relatively stable, the number of cells with a reduced chro-
mosome count (<91 chromosomes) increased at 6 weeks after DC
treatment. This reduction of chromosome number at later pas-
sages was also observed in tetraploid cells established from TIG-1
human fibroblasts (6). These observations suggest that polyploid
cells lose their chromosomes during cultivation and are converted
into aneuploid cells. The propagation of aneuploid cells should be
confirmed, however, because it was shown that the p53 pathway
plays an important role in limiting the propagation of aneuploid
human cells in culture (22).
Most of established tetraploid mitotic cells had only two cen-
trosomes with bipolar spindles like diploid cells, and this might
contribute to stable propagation of tetraploid cells and stability
of chromosome number. Recent studies show that supernumer-
ary centrosomes in cancer cells and non-transformed tetraploid
cells are often clustered into two spindle poles, which enables
bipolar divisions (19, 23). However, most centrosomes in estab-
lished tetraploid BJ cells consisted of only two centrioles, sug-
gesting these cells were established by mechanisms different from
the clustering of excess centrosomes. These observations regard-
ing centrosomes were exactly the same as the observations for
tetraploid cells established from TIG-1 fibroblasts in the previous
study (6).
The method described in this study is likely to be applic-
able to other fibroblast strains too, because the induction of
tetraploidy in the human fibroblast strain IMR-90 was also con-
firmed (unpublished data). In other studies, mouse tetraploid cells
were used to show the promotion of tumorigenesis by tetraploidy
(24, 25); however, in these studies, fluorescence-activated cell sort-
ing (FACS) was used to isolate tetraploid cells from diploid cells.
Our method has the advantage that the induction of tetraploid
cells can be achieved easily without FACS. Tetraploid cells estab-
lished by our method may be of value as a model for studying
the chromosomal instability and oncogenic potential of polyploid
cells.
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